PharmaMedic Consultancy is delighted to announce its sponsorship of the ‘Excellence in Rare Diseases and Orphan Drugs" category at the 2020 Pharmaceutical Market Excellence Awards (PMEA).
From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be making independent regulatory decisions. Guidelines are in place, and the ABPI has called for support to help sponsors navigate the changes. Read on to learn more about this new era of independence for the agency.
In our latest article, we explore how PharmaMedic Consultancy (PMC®) supports Glenmark Pharmaceuticals with their day to day promotional activities. Read on to learn how our medical affairs consultant seamlessly fits into our client's team and ensures commercial compliance.
Collaboration is essential to drive innovation in pharma and bring new medicines to patients. In this article, we discuss how close cooperation between regulatory and medical affairs helps to streamline regulatory interactions.
In this second article in our consultant Q&A series, we sat down with Sarah Hollywood, to learn about her experiences working on medical affairs projects with PharmaMedic. If you’re thinking of taking the plunge into medical or regulatory affairs consultancy, read the article for Sarah’s account of life as a PharmaMedic consultant.
In this new article, we sit down with Lucy Cook, one of the PharmaMedic Consultancy network to talk about her experience in medical affairs, work-life balance, and how PharmaMedic Consultancy helps her to do more of the technical work she enjoys without the traditional headaches of self-employment.
Now more than ever, we need to apply old-fashioned common sense to help drive advances in healthcare. In this article we discuss how reconfiguring and repurposing of medicines have come to the fore during the COVID-19 pandemic.
With the COVID-19 pandemic disrupting medical provision across the globe, healthcare providers urgently need to improve efficiency of patient care. Read our new article to learn how artificial intelligence is being used in clinical decision-making.
Like all sectors, the pharmaceutical industry is facing an unparalleled period of uncertainty. As experienced pharmaceutical consultants, we are well equipped to adapt, thrive and add value in this changing environment. In this article, we explore some of the skills and qualities that we need to embrace now more than ever.
PharmaMedic's VirtualPharma™ Solution is backed by decades of medical affairs experience and built on four key pillars. Read more to learn how we help pharma and biotech companies of all sizes with flexible solutions.
